Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06870825

Assessment of Quadriceps Femoris Muscle Function in Patients After Arthroscopic Knee Surgery in Outpatient Rehabilitation

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Lithuanian University of Health Sciences · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if a high intensity magnetic field is an effective way to treat quadriceps muscle atrophy after knee arthroscopic surgery in adult patients. The main questions it aims to answer are: Is high intensity magnetic field muscle stimulation is an effective way to treat quadriceps muscle atrophy Is high intensity magnetic field muscle stimulation is more effective and more tolerable option for quadriceps muscle stimulation than transcutaneous muscle electrical stimulation Researchers will compare high intensity magnetic field muscle stimulation to transcutaneous muscle electrical stimulation and control group, to see if high intensity magnetic field muscle stimulation works to treat quadriceps muscle atrophy. Participants will: receive high intensity magnetic field or transcutaneous muscle electrical stimulation 1 time/day for 14 days, Visit the rehabilitation department for testing before/after and 1 month after rehabilitation.

Detailed description

The purpose of this study is to evaluate the effectiveness of quadriceps muscle stimulation methods: transcutaneous neuromuscular electrostimulation (standard methodology) and high-intensity magnetic field (innovative methodology) stimulation in the rehabilitation of patients after arthroscopic knee surgery, and the impact of the applied methods on the quality of life. Objectives: 1. To evaluate and check the quadriceps muscle volume, strength, knee joint motion amplitude, pain intensity before and after outpatient rehabilitation and to identify factors that may influence their occurrence. 2. To evaluate and compare the effectiveness of transcutaneous neuromuscular electrical stimulation and high-intensity magnetic field stimulation on changes in quadriceps muscle volume and strength in patients undergoing outpatient rehabilitation after knee joint arthroscopic surgeries. 3. To evaluate the impact of quadriceps muscle size and strength reduction on movement function and quality of life during outpatient rehabilitation, to evaluate changes in condition after outpatient rehabilitation and the previous 1 month, to compare the results obtained. 4. To establish and compare the tolerance of different muscle stimulation methods used and possible adverse reactions after arthroscopic knee joint surgeries. Subject of the study: Patients undergoing outpatient rehabilitation, according to the profile of musculoskeletal injuries, 14 days.

Conditions

Interventions

TypeNameDescription
DEVICEHigh-intensity Magnetic Field Muscle Stimulation1. The procedure is performed for 20 min., 1k/d, 5k/week, a total of 14 times (rehabilitation duration 14 days). 2. Parameters: applied parameters according to the manufacturer's specified program for muscle stimulation: "muscle strengthening" program 3. Stimulation site: quadriceps femoris muscle, applied above the motor point approximately 60% of the distance from the upper medial border of the patella to the anterior upper wing of the iliac bone. 4. device: BLT Super Inductive System * Along with muscle stimulation techniques, all subjects will undergo a standardized outpatient rehabilitation plan.
DEVICETranscutaneous Neuromuscular Electrical Stimulation1. the procedure is performed for 20 min., 1k/d, 5k/week, a total of 14 times (rehab. duration 14 days). 2. Parameters: applied parameters according to the manufacturer's specified program for muscle stimulation (EMS, P3) 3. Stimulation site: quadriceps femoris muscle, applied above the motor point. 4. device: ITO ES-5200 * Along with muscle stimulation techniques, all subjects will undergo a standardized outpatient rehabilitation plan.

Timeline

Start date
2025-01-01
Primary completion
2027-03-30
Completion
2027-08-01
First posted
2025-03-11
Last updated
2025-03-11

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT06870825. Inclusion in this directory is not an endorsement.